Henry Schein Net Cash Flow 2010-2024 | HSIC

Henry Schein annual/quarterly net cash flow history and growth rate from 2010 to 2024. Net cash flow can be defined as the total change in cash for the company over the given period.
  • Henry Schein net cash flow for the quarter ending December 31, 2024 was $-49M, a 190.74% decline year-over-year.
  • Henry Schein net cash flow for the twelve months ending December 31, 2024 was $-0.139B, a 205.3% decline year-over-year.
  • Henry Schein annual net cash flow for 2024 was $-0.049B, a 190.74% decline from 2023.
  • Henry Schein annual net cash flow for 2023 was $0.054B, a 5500% decline from 2022.
  • Henry Schein annual net cash flow for 2022 was $-0.001B, a 99.67% decline from 2021.
Henry Schein Annual Net Cash Flow
(Millions of US $)
2024 $-49
2023 $54
2022 $-1
2021 $-303
2020 $315
2019 $49
2018 $-101
2017 $115
2016 $-10
2015 $-17
2014 $-99
2013 $67
2012 $-25
2011 $-3
2010 $-321
2009 $102
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $8.708B $12.673B
Henry Schein Inc. is a leading distributor of health care products and services across the globe. The company serves office-based dental, medical and animal health practitioners, dental laboratories, government as well as institutional health care clinics and other alternate-care sites. Henry Schein's 3 businesses - Dental, Medical and Technology and Value-Added Services serve millions of customers worldwide. Henry Schein has completed the spinoff of its global Animal Health business. The global dental group serves office-based dental practitioners, dental laboratories, schools and other institutions. The global medical group serves office-based medical practitioners, ambulatory surgery centers, other alternate-care settings and other institutions. The global technology and value-added services group provides software, technology and other value-added services to health care practitioners. The technology group offerings include practice management software systems for dental and medical practitioners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $88.424B 21.35
Becton Dickinson (BDX) United States $49.374B 12.23
Cardinal Health (CAH) United States $36.267B 18.99
Straumann Holding AG (SAUHY) Switzerland $21.415B 0.00
Labcorp (LH) United States $20.613B 16.72
Cooper (COO) United States $16.288B 21.60
West Pharmaceutical Services (WST) United States $15.136B 31.73
Align Technology (ALGN) United States $13.534B 26.87
Merit Medical Systems (MMSI) United States $5.766B 27.88
DENTSPLY SIRONA (XRAY) United States $3.288B 9.82
CONMED (CNMD) United States $1.847B 13.82
STAAR Surgical (STAA) United States $0.906B 0.00
Lifevantage (LFVN) United States $0.159B 16.38
Pro-Dex (PDEX) United States $0.141B 15.40